Vistim Labs Closes First Round of Funding
May 11, 2023
Altitude Lab recently announced that Vistim Labs, one of their current first year companies, has successfully closed its seed round, oversubscribed at $800,000. According to Altitude’s report, completing this round will finance Vistim’s go-to-market this year and allow them to raise another $2M this fall to scale their sales in 2024.
Recent News
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome
- Sera Prognostics Appoints Scott Gleason CFO
- Merit Medical Announces Global Operations Leadership Transition
- Utah Life Sciences Innovation Caucus Breakfast
- Curavit Expands Clinical Research Capabilities with Acquisition of Lindus Health CRO Assets, Accelerating Global Trial Execution for Life Science Sponsors
